Global Hydroxychloroquine (Plaquenil) Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 113
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 100mg

- 200mg

- Other

Segment by Application

- Lupus Erythematosus

- Rheumatoid Arthritis

- COVID-19

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Sanofi

- Actavis (TEVA )

- Mylan

- Novartis

- Covis Pharmaceutical

- Cardinal Health

- Apotex Corporation

- Hikma Pharmaceuticals

- Aphena Pharma

- Concordia Healthcare

- AvKARE (Amneal Pharmaceuticals)

- Ipca Laboratories

- Shanghai Pharmaceuticals Holding

- Taj Pharmaceuticals

- Cinkate Corporation

- Cadila Healthcare

- Sun Pharma

- Zydus Cadila

- Advanz Pharma

- Bristol Laboratories

- Hanlim Pharmaceutical

- Kyung Poong

Global Hydroxychloroquine (Plaquenil) Market Research Report 2022

Table of Contents
1 Hydroxychloroquine (Plaquenil) Market Overview
1.1 Product Overview and Scope of Hydroxychloroquine (Plaquenil)
1.2 Hydroxychloroquine (Plaquenil) Segment by Type
1.2.1 Global Hydroxychloroquine (Plaquenil) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 100mg
1.2.3 200mg
1.2.4 Other
1.3 Hydroxychloroquine (Plaquenil) Segment by Application
1.3.1 Global Hydroxychloroquine (Plaquenil) Sales Comparison by Application: (2022-2028)
1.3.2 Lupus Erythematosus
1.3.3 Rheumatoid Arthritis
1.3.4 COVID-19
1.3.5 Others
1.4 Global Hydroxychloroquine (Plaquenil) Market Size Estimates and Forecasts
1.4.1 Global Hydroxychloroquine (Plaquenil) Revenue 2017-2028
1.4.2 Global Hydroxychloroquine (Plaquenil) Sales 2017-2028
1.4.3 Hydroxychloroquine (Plaquenil) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Hydroxychloroquine (Plaquenil) Market Competition by Manufacturers
2.1 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Hydroxychloroquine (Plaquenil) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Hydroxychloroquine (Plaquenil) Manufacturing Sites, Area Served, Product Type
2.5 Hydroxychloroquine (Plaquenil) Market Competitive Situation and Trends
2.5.1 Hydroxychloroquine (Plaquenil) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hydroxychloroquine (Plaquenil) Players Market Share by Revenue
2.5.3 Global Hydroxychloroquine (Plaquenil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hydroxychloroquine (Plaquenil) Retrospective Market Scenario by Region
3.1 Global Hydroxychloroquine (Plaquenil) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Hydroxychloroquine (Plaquenil) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Hydroxychloroquine (Plaquenil) Market Facts & Figures by Country
3.3.1 North America Hydroxychloroquine (Plaquenil) Sales by Country
3.3.2 North America Hydroxychloroquine (Plaquenil) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hydroxychloroquine (Plaquenil) Market Facts & Figures by Country
3.4.1 Europe Hydroxychloroquine (Plaquenil) Sales by Country
3.4.2 Europe Hydroxychloroquine (Plaquenil) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hydroxychloroquine (Plaquenil) Market Facts & Figures by Region
3.5.1 Asia Pacific Hydroxychloroquine (Plaquenil) Sales by Region
3.5.2 Asia Pacific Hydroxychloroquine (Plaquenil) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hydroxychloroquine (Plaquenil) Market Facts & Figures by Country
3.6.1 Latin America Hydroxychloroquine (Plaquenil) Sales by Country
3.6.2 Latin America Hydroxychloroquine (Plaquenil) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hydroxychloroquine (Plaquenil) Market Facts & Figures by Country
3.7.1 Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country
3.7.2 Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hydroxychloroquine (Plaquenil) Historic Market Analysis by Type
4.1 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2017-2022)
4.2 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2017-2022)
4.3 Global Hydroxychloroquine (Plaquenil) Price by Type (2017-2022)
5 Global Hydroxychloroquine (Plaquenil) Historic Market Analysis by Application
5.1 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2017-2022)
5.2 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2017-2022)
5.3 Global Hydroxychloroquine (Plaquenil) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Actavis (TEVA )
6.2.1 Actavis (TEVA ) Corporation Information
6.2.2 Actavis (TEVA ) Description and Business Overview
6.2.3 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio
6.2.5 Actavis (TEVA ) Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Mylan Hydroxychloroquine (Plaquenil) Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Hydroxychloroquine (Plaquenil) Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Covis Pharmaceutical
6.5.1 Covis Pharmaceutical Corporation Information
6.5.2 Covis Pharmaceutical Description and Business Overview
6.5.3 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
6.5.5 Covis Pharmaceutical Recent Developments/Updates
6.6 Cardinal Health
6.6.1 Cardinal Health Corporation Information
6.6.2 Cardinal Health Description and Business Overview
6.6.3 Cardinal Health Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio
6.6.5 Cardinal Health Recent Developments/Updates
6.7 Apotex Corporation
6.6.1 Apotex Corporation Corporation Information
6.6.2 Apotex Corporation Description and Business Overview
6.6.3 Apotex Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
6.7.5 Apotex Corporation Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Aphena Pharma
6.9.1 Aphena Pharma Corporation Information
6.9.2 Aphena Pharma Description and Business Overview
6.9.3 Aphena Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
6.9.5 Aphena Pharma Recent Developments/Updates
6.10 Concordia Healthcare
6.10.1 Concordia Healthcare Corporation Information
6.10.2 Concordia Healthcare Description and Business Overview
6.10.3 Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
6.10.5 Concordia Healthcare Recent Developments/Updates
6.11 AvKARE (Amneal Pharmaceuticals)
6.11.1 AvKARE (Amneal Pharmaceuticals) Corporation Information
6.11.2 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Description and Business Overview
6.11.3 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio
6.11.5 AvKARE (Amneal Pharmaceuticals) Recent Developments/Updates
6.12 Ipca Laboratories
6.12.1 Ipca Laboratories Corporation Information
6.12.2 Ipca Laboratories Hydroxychloroquine (Plaquenil) Description and Business Overview
6.12.3 Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
6.12.5 Ipca Laboratories Recent Developments/Updates
6.13 Shanghai Pharmaceuticals Holding
6.13.1 Shanghai Pharmaceuticals Holding Corporation Information
6.13.2 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Description and Business Overview
6.13.3 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio
6.13.5 Shanghai Pharmaceuticals Holding Recent Developments/Updates
6.14 Taj Pharmaceuticals
6.14.1 Taj Pharmaceuticals Corporation Information
6.14.2 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Description and Business Overview
6.14.3 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
6.14.5 Taj Pharmaceuticals Recent Developments/Updates
6.15 Cinkate Corporation
6.15.1 Cinkate Corporation Corporation Information
6.15.2 Cinkate Corporation Hydroxychloroquine (Plaquenil) Description and Business Overview
6.15.3 Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
6.15.5 Cinkate Corporation Recent Developments/Updates
6.16 Cadila Healthcare
6.16.1 Cadila Healthcare Corporation Information
6.16.2 Cadila Healthcare Hydroxychloroquine (Plaquenil) Description and Business Overview
6.16.3 Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
6.16.5 Cadila Healthcare Recent Developments/Updates
6.17 Sun Pharma
6.17.1 Sun Pharma Corporation Information
6.17.2 Sun Pharma Hydroxychloroquine (Plaquenil) Description and Business Overview
6.17.3 Sun Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
6.17.5 Sun Pharma Recent Developments/Updates
6.18 Zydus Cadila
6.18.1 Zydus Cadila Corporation Information
6.18.2 Zydus Cadila Hydroxychloroquine (Plaquenil) Description and Business Overview
6.18.3 Zydus Cadila Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio
6.18.5 Zydus Cadila Recent Developments/Updates
6.19 Advanz Pharma
6.19.1 Advanz Pharma Corporation Information
6.19.2 Advanz Pharma Hydroxychloroquine (Plaquenil) Description and Business Overview
6.19.3 Advanz Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
6.19.5 Advanz Pharma Recent Developments/Updates
6.20 Bristol Laboratories
6.20.1 Bristol Laboratories Corporation Information
6.20.2 Bristol Laboratories Hydroxychloroquine (Plaquenil) Description and Business Overview
6.20.3 Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
6.20.5 Bristol Laboratories Recent Developments/Updates
6.21 Hanlim Pharmaceutical
6.21.1 Hanlim Pharmaceutical Corporation Information
6.21.2 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Description and Business Overview
6.21.3 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
6.21.5 Hanlim Pharmaceutical Recent Developments/Updates
6.22 Kyung Poong
6.22.1 Kyung Poong Corporation Information
6.22.2 Kyung Poong Hydroxychloroquine (Plaquenil) Description and Business Overview
6.22.3 Kyung Poong Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio
6.22.5 Kyung Poong Recent Developments/Updates
7 Hydroxychloroquine (Plaquenil) Manufacturing Cost Analysis
7.1 Hydroxychloroquine (Plaquenil) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hydroxychloroquine (Plaquenil)
7.4 Hydroxychloroquine (Plaquenil) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hydroxychloroquine (Plaquenil) Distributors List
8.3 Hydroxychloroquine (Plaquenil) Customers
9 Hydroxychloroquine (Plaquenil) Market Dynamics
9.1 Hydroxychloroquine (Plaquenil) Industry Trends
9.2 Hydroxychloroquine (Plaquenil) Market Drivers
9.3 Hydroxychloroquine (Plaquenil) Market Challenges
9.4 Hydroxychloroquine (Plaquenil) Market Restraints
10 Global Market Forecast
10.1 Hydroxychloroquine (Plaquenil) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hydroxychloroquine (Plaquenil) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Hydroxychloroquine (Plaquenil) by Type (2023-2028)
10.2 Hydroxychloroquine (Plaquenil) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hydroxychloroquine (Plaquenil) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Hydroxychloroquine (Plaquenil) by Application (2023-2028)
10.3 Hydroxychloroquine (Plaquenil) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hydroxychloroquine (Plaquenil) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Hydroxychloroquine (Plaquenil) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hydroxychloroquine (Plaquenil) Sales Growth Rate Comparison by Type (2022-2028) & (M Pcs) & (US$ Million)
Table 2. Global Hydroxychloroquine (Plaquenil) Sales Growth Rate Comparison by Application (2022-2028) & (M Pcs) & (US$ Million)
Table 3. Global Hydroxychloroquine (Plaquenil) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Hydroxychloroquine (Plaquenil) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Hydroxychloroquine (Plaquenil) Sales (M Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Hydroxychloroquine (Plaquenil) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Hydroxychloroquine (Plaquenil) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Hydroxychloroquine (Plaquenil) Average Price (US$/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Hydroxychloroquine (Plaquenil) Manufacturing Sites and Area Served
Table 11. Manufacturers Hydroxychloroquine (Plaquenil) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hydroxychloroquine (Plaquenil) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxychloroquine (Plaquenil) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hydroxychloroquine (Plaquenil) Sales by Region (2017-2022) & (M Pcs)
Table 16. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2017-2022)
Table 17. Global Hydroxychloroquine (Plaquenil) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2017-2022)
Table 19. North America Hydroxychloroquine (Plaquenil) Sales by Country (2017-2022) & (M Pcs)
Table 20. North America Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2017-2022)
Table 21. North America Hydroxychloroquine (Plaquenil) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Hydroxychloroquine (Plaquenil) Revenue Market Share by Country (2017-2022)
Table 23. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2017-2022) & (M Pcs)
Table 24. Europe Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2017-2022)
Table 25. Europe Hydroxychloroquine (Plaquenil) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Hydroxychloroquine (Plaquenil) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Hydroxychloroquine (Plaquenil) Sales by Region (2017-2022) & (M Pcs)
Table 28. Asia Pacific Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Hydroxychloroquine (Plaquenil) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Hydroxychloroquine (Plaquenil) Sales by Country (2017-2022) & (M Pcs)
Table 32. Latin America Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2017-2022)
Table 33. Latin America Hydroxychloroquine (Plaquenil) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Hydroxychloroquine (Plaquenil) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country (2017-2022) & (M Pcs)
Table 36. Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue Market Share by Country (2017-2022)
Table 39. Global Hydroxychloroquine (Plaquenil) Sales by Type (2017-2022) & (M Pcs)
Table 40. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2017-2022)
Table 41. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Hydroxychloroquine (Plaquenil) Revenue Share by Type (2017-2022)
Table 43. Global Hydroxychloroquine (Plaquenil) Price by Type (2017-2022) & (US$/Pcs)
Table 44. Global Hydroxychloroquine (Plaquenil) Sales (M Pcs) by Application (2017-2022)
Table 45. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2017-2022)
Table 46. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Hydroxychloroquine (Plaquenil) Revenue Share by Application (2017-2022)
Table 48. Global Hydroxychloroquine (Plaquenil) Price by Application (2017-2022) & (US$/Pcs)
Table 49. Sanofi Corporation Information
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 52. Sanofi Hydroxychloroquine (Plaquenil) Product
Table 53. Sanofi Recent Developments/Updates
Table 54. Actavis (TEVA ) Corporation Information
Table 55. Actavis (TEVA ) Description and Business Overview
Table 56. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 57. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product
Table 58. Actavis (TEVA ) Recent Developments/Updates
Table 59. Mylan Corporation Information
Table 60. Mylan Description and Business Overview
Table 61. Mylan Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 62. Mylan Hydroxychloroquine (Plaquenil) Product
Table 63. Mylan Recent Developments/Updates
Table 64. Novartis Corporation Information
Table 65. Novartis Description and Business Overview
Table 66. Novartis Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 67. Novartis Hydroxychloroquine (Plaquenil) Product
Table 68. Novartis Recent Developments/Updates
Table 69. Covis Pharmaceutical Corporation Information
Table 70. Covis Pharmaceutical Description and Business Overview
Table 71. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 72. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product
Table 73. Covis Pharmaceutical Recent Developments/Updates
Table 74. Cardinal Health Corporation Information
Table 75. Cardinal Health Description and Business Overview
Table 76. Cardinal Health Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 77. Cardinal Health Hydroxychloroquine (Plaquenil) Product
Table 78. Cardinal Health Recent Developments/Updates
Table 79. Apotex Corporation Corporation Information
Table 80. Apotex Corporation Description and Business Overview
Table 81. Apotex Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 82. Apotex Corporation Hydroxychloroquine (Plaquenil) Product
Table 83. Apotex Corporation Recent Developments/Updates
Table 84. Hikma Pharmaceuticals Corporation Information
Table 85. Hikma Pharmaceuticals Description and Business Overview
Table 86. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 87. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product
Table 88. Hikma Pharmaceuticals Recent Developments/Updates
Table 89. Aphena Pharma Corporation Information
Table 90. Aphena Pharma Description and Business Overview
Table 91. Aphena Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 92. Aphena Pharma Hydroxychloroquine (Plaquenil) Product
Table 93. Aphena Pharma Recent Developments/Updates
Table 94. Concordia Healthcare Corporation Information
Table 95. Concordia Healthcare Description and Business Overview
Table 96. Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 97. Concordia Healthcare Hydroxychloroquine (Plaquenil) Product
Table 98. Concordia Healthcare Recent Developments/Updates
Table 99. AvKARE (Amneal Pharmaceuticals) Corporation Information
Table 100. AvKARE (Amneal Pharmaceuticals) Description and Business Overview
Table 101. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 102. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product
Table 103. AvKARE (Amneal Pharmaceuticals) Recent Developments/Updates
Table 104. Ipca Laboratories Corporation Information
Table 105. Ipca Laboratories Description and Business Overview
Table 106. Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 107. Ipca Laboratories Hydroxychloroquine (Plaquenil) Product
Table 108. Ipca Laboratories Recent Developments/Updates
Table 109. Shanghai Pharmaceuticals Holding Corporation Information
Table 110. Shanghai Pharmaceuticals Holding Description and Business Overview
Table 111. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 112. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product
Table 113. Shanghai Pharmaceuticals Holding Recent Developments/Updates
Table 114. Taj Pharmaceuticals Corporation Information
Table 115. Taj Pharmaceuticals Description and Business Overview
Table 116. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 117. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product
Table 118. Taj Pharmaceuticals Recent Developments/Updates
Table 119. Cinkate Corporation Corporation Information
Table 120. Cinkate Corporation Description and Business Overview
Table 121. Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 122. Cinkate Corporation Hydroxychloroquine (Plaquenil) Product
Table 123. Cinkate Corporation Recent Developments/Updates
Table 124. Cadila Healthcare Corporation Information
Table 125. Cadila Healthcare Description and Business Overview
Table 126. Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 127. Cadila Healthcare Hydroxychloroquine (Plaquenil) Product
Table 128. Cadila Healthcare Recent Developments/Updates
Table 129. Sun Pharma Corporation Information
Table 130. Sun Pharma Description and Business Overview
Table 131. Sun Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 132. Sun Pharma Hydroxychloroquine (Plaquenil) Product
Table 133. Sun Pharma Recent Developments/Updates
Table 134. Zydus Cadila Corporation Information
Table 135. Zydus Cadila Description and Business Overview
Table 136. Zydus Cadila Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 137. Zydus Cadila Hydroxychloroquine (Plaquenil) Product
Table 138. Zydus Cadila Recent Developments/Updates
Table 139. Advanz Pharma Corporation Information
Table 140. Advanz Pharma Description and Business Overview
Table 141. Advanz Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 142. Advanz Pharma Hydroxychloroquine (Plaquenil) Product
Table 143. Advanz Pharma Recent Developments/Updates
Table 144. Bristol Laboratories Corporation Information
Table 145. Bristol Laboratories Description and Business Overview
Table 146. Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 147. Bristol Laboratories Hydroxychloroquine (Plaquenil) Product
Table 148. Bristol Laboratories Recent Developments/Updates
Table 149. Hanlim Pharmaceutical Corporation Information
Table 150. Hanlim Pharmaceutical Description and Business Overview
Table 151. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 152. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product
Table 153. Hanlim Pharmaceutical Recent Developments/Updates
Table 154. Kyung Poong Corporation Information
Table 155. Kyung Poong Description and Business Overview
Table 156. Kyung Poong Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 157. Kyung Poong Hydroxychloroquine (Plaquenil) Product
Table 158. Kyung Poong Recent Developments/Updates
Table 159. Production Base and Market Concentration Rate of Raw Material
Table 160. Key Suppliers of Raw Materials
Table 161. Hydroxychloroquine (Plaquenil) Distributors List
Table 162. Hydroxychloroquine (Plaquenil) Customers List
Table 163. Hydroxychloroquine (Plaquenil) Market Trends
Table 164. Hydroxychloroquine (Plaquenil) Market Drivers
Table 165. Hydroxychloroquine (Plaquenil) Market Challenges
Table 166. Hydroxychloroquine (Plaquenil) Market Restraints
Table 167. Global Hydroxychloroquine (Plaquenil) Sales Forecast by Type (2023-2028) & (M Pcs)
Table 168. Global Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Type (2023-2028)
Table 169. Global Hydroxychloroquine (Plaquenil) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 170. Global Hydroxychloroquine (Plaquenil) Revenue Market Share Forecast by Type (2023-2028)
Table 171. Global Hydroxychloroquine (Plaquenil) Sales Forecast by Application (2023-2028) & (M Pcs)
Table 172. Global Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Application (2023-2028)
Table 173. Global Hydroxychloroquine (Plaquenil) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 174. Global Hydroxychloroquine (Plaquenil) Revenue Market Share Forecast by Application (2023-2028)
Table 175. Global Hydroxychloroquine (Plaquenil) Sales Forecast by Region (2023-2028) & (M Pcs)
Table 176. Global Hydroxychloroquine (Plaquenil) Sales Market Share Forecast by Region (2023-2028)
Table 177. Global Hydroxychloroquine (Plaquenil) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 178. Global Hydroxychloroquine (Plaquenil) Revenue Market Share Forecast by Region (2023-2028)
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hydroxychloroquine (Plaquenil)
Figure 2. Global Hydroxychloroquine (Plaquenil) Market Share by Type in 2021 & 2028
Figure 3. 100mg Product Picture
Figure 4. 200mg Product Picture
Figure 5. Other Product Picture
Figure 6. Global Hydroxychloroquine (Plaquenil) Market Share by Application in 2021 & 2028
Figure 7. Lupus Erythematosus
Figure 8. Rheumatoid Arthritis
Figure 9. COVID-19
Figure 10. Others
Figure 11. Global Hydroxychloroquine (Plaquenil) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Hydroxychloroquine (Plaquenil) Market Size (2017-2028) & (US$ Million)
Figure 13. Global Hydroxychloroquine (Plaquenil) Sales (2017-2028) & (M Pcs)
Figure 14. Hydroxychloroquine (Plaquenil) Sales Share by Manufacturers in 2021
Figure 15. Global Hydroxychloroquine (Plaquenil) Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Hydroxychloroquine (Plaquenil) Players: Market Share by Revenue in 2021
Figure 17. Hydroxychloroquine (Plaquenil)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs